strain
takara
bio
inc
tokyo
japan
use
plasmid
construct
ripl
strain
stratagen
la
jolla
ca
usa
use
express
recombin
protein
construct
express
plasmid
encod
glutathion
stransferas
gst
fusion
protein
part
polyprotein
noroviru
chiba
strain
fig
dna
fragment
amplifi
vent
dna
polymeras
neb
ipswich
usa
primer
tabl
use
encod
entir
templat
amplifi
dna
fragment
encod
ctermin
amino
acid
region
plu
entir
vpg
region
digest
bamhi
smai
restrict
enzym
clone
correspond
site
ge
healthcar
piscataway
nj
usa
sinc
gst
fusion
protein
contain
cleavag
site
cleav
three
protein
vpg
proteas
e
coli
cell
transform
wildtyp
plasmid
fig
mutat
introduc
result
plasmid
design
x
introduc
amino
acid
written
onelett
code
mutagen
primer
list
tabl
mutat
digest
dna
fragment
amplifi
primer
digest
dna
fragment
amplifi
primer
clone
mutat
introduc
primer
use
quikchang
ii
sitedirect
mutagenesi
kit
stratagen
kind
mutat
primestar
max
dna
polymeras
takara
bio
inc
use
mutat
first
detect
restrict
analysi
verifi
dna
sequenc
unexpect
mutat
introduc
fragment
exchang
correspond
region
construct
transfer
fragment
correspond
region
mutat
introduc
transfer
fragment
respect
plasmid
result
construct
seri
plasmid
vitro
assay
proteas
activ
construct
ligat
fragment
fragment
ge
healthcar
although
backbon
construct
studi
vector
thrombin
site
gst
proteas
presciss
proteas
site
fragment
mutant
plasmid
contain
mutat
andor
transfer
result
mutant
plasmid
escherichia
coli
ripl
cell
transform
plasmid
grown
ml
magicmedia
e
coli
express
medium
invitrogen
carlsbad
ca
usa
h
cell
harvest
resuspend
pb
contain
triton
onehalf
volum
glass
bead
mm
diamet
ad
cell
suspens
follow
vigor
vortex
min
centrifug
g
min
supernat
transfer
new
tube
protein
determin
bca
protein
assay
kit
pierc
biotechnolog
rockford
il
usa
use
bsa
standard
extract
protein
separ
follow
stain
coomassi
brilliant
blue
western
blot
rabbit
polyclon
antigst
abcam
cambridg
usa
antivpg
antiproteas
antibodi
alkalin
phosphatas
horseradish
peroxidaseconjug
antirabbit
igg
rockland
gilbertsvil
pa
usa
use
secondari
antibodi
chemiluminesc
develop
immobilon
western
reagent
millipor
billerica
usa
measur
luminoimag
analys
fujifilm
tokyo
japan
cell
extract
contain
mg
protein
appli
glutathion
sepharos
microspin
column
ge
healthcar
follow
lowspe
centrifug
g
min
glutathionresinbound
protein
elut
mm
ph
buffer
contain
mm
reduc
glutathion
portion
eluat
analys
escherichia
coli
ripl
cell
harbor
plasmid
grown
magicmedia
e
coli
express
medium
h
protein
extract
describ
fusion
protein
purifi
pass
cell
extract
glutathionesepharos
fast
flow
resin
ge
healthcar
assay
proteas
activ
fluorogen
peptid
synthes
peptid
institut
inc
osaka
japan
sequenc
peptid
nmaglupheglnmetglnglyglnv
dnp
dargdarg
includ
sequenc
protein
chiba
viru
fluoresc
nma
nmethylamino
benzoyl
moieti
quench
dnp
moieti
undigest
increas
peptid
bond
gln
gli
cleav
proteas
fluoresc
monitor
hitachi
fluoresc
spectrophotomet
tokyo
japan
excit
wavelength
nm
emiss
wavelength
nm
proteas
activ
assay
mm
ph
buffer
contain
purifi
protein
fluorogen
peptid
determin
kinet
constant
assay
perform
mm
ph
buffer
contain
purifi
protein
variou
concentr
fluorogen
peptid
peptid
dissolv
dmso
store
stock
solut
peptid
ad
assay
mixtur
final
concentr
dmso
calcul
amount
cleav
substrat
fluoresc
intens
refer
compound
mixtur
nmalabel
dnplabel
peptid
institut
inc
concentr
measur
compar
amount
chang
fluoresc
accompani
enzym
reaction
kinet
constant
calcul
plot
initi
rate
proteolysi
versu
concentr
peptid
shown
fig
fusion
protein
includ
wildtyp
proteas
deriv
cleav
vpg
proteas
e
coli
cell
without
trace
noncleav
protein
intermedi
indic
proteas
fulli
activ
e
coli
cell
hand
mutant
protein
cleav
indic
ala
mutat
nucleophil
inactiv
enzym
complet
shown
previous
previous
conclud
essenti
proteas
activ
sinc
mutat
affect
activ
ident
mutat
introduc
mutant
protein
express
shown
fig
mutat
affect
cleavag
furthermor
surpris
mutant
retain
signific
proteolyt
activ
judg
express
e
coli
cell
fig
base
mainli
result
gst
bind
assay
effect
mutat
could
roughli
group
five
categori
fig
mutat
gave
level
activ
compar
wildtyp
consist
ala
cy
asp
gli
gln
ser
ii
mutat
affect
activ
slightli
left
small
amount
intermedi
consist
met
asn
iii
mutat
markedli
affect
activ
result
small
amount
intermedi
consist
trp
iv
mutat
affect
process
intermedi
vpg
consist
ile
leu
pro
v
mutat
inactiv
enzym
complet
consist
phe
ly
arg
thr
val
tyr
result
gst
bind
assay
essenti
western
blot
antigst
antibodi
data
shown
mutant
shorter
carboxyl
glutam
mutant
neutral
amid
version
glutam
exhibit
wildtyp
proteas
activ
although
faint
band
intermedi
observ
mutant
fig
mutant
neutral
amid
version
aspart
also
show
rel
high
activ
intermedi
remain
fig
result
indic
abil
form
hydrogen
bond
import
amino
acid
posit
rather
neg
charg
contrast
shown
previou
paper
mutant
also
retain
high
activ
compar
wildtyp
although
small
amount
intermedi
parent
protein
detect
fig
moreov
mutant
small
amino
acid
residu
posit
exhibit
wildtyp
activ
western
blot
data
shown
small
amino
acid
mutant
possibl
water
molecul
locat
side
chain
amino
acid
posit
interact
imidazol
ring
idea
would
support
fact
water
molecul
interact
correspond
noroviru
proteas
sinc
coronaviru
main
proteas
proteas
possess
posit
equival
noroviru
proteas
hand
surpris
mutant
show
activ
threonin
residu
addit
methyl
residu
atom
compar
serin
residu
mutant
also
proteas
activ
side
chain
valin
residu
similar
threonin
residu
except
methyl
group
substitut
hydroxyl
group
long
consid
result
two
mutant
could
assum
amino
acid
two
substitu
group
atom
inhibitori
exert
proteolysi
howev
mutant
show
signific
proteas
activ
although
isoleucin
two
substitu
group
methyl
ethyl
atom
bigger
valin
also
mutant
leucin
side
chain
volum
isoleucin
methyl
attach
atom
mutant
show
activ
similar
mutant
notabl
activ
three
mutant
limit
fuse
parent
cleav
proteas
intermedi
rare
cleav
vpg
fig
result
indic
proteas
mutat
activ
precursor
form
almost
inact
matur
form
interest
intermedi
produc
three
mutant
fig
result
suggest
cleavag
preced
cleavag
precursor
form
might
subtli
differ
matur
form
proteas
least
catalyt
centr
cleavag
conform
proteas
might
lock
proteas
longer
exert
catalysi
although
precis
mechan
unknown
anoth
possibl
name
residu
posit
involv
affect
substrat
recognit
howev
seem
rather
unlik
sinc
far
substrat
accord
model
substrat
bind
proteas
novel
phenomenon
observ
mutant
seen
mutant
describ
mutant
describ
mutant
result
product
intermedi
well
intermedi
although
amount
produc
appear
slightli
less
amount
fig
obvious
indic
proteas
possibl
matur
proteas
form
precursor
form
abl
cleav
site
suggest
virtual
differ
way
cleav
two
site
henc
differ
structur
precursor
matur
form
proteas
like
introduct
posit
charg
residu
lysin
arginin
posit
detriment
proteas
made
protein
unstabl
sinc
mutant
protein
hardli
express
fig
contrast
mutant
show
signific
proteas
activ
compar
mutant
fig
although
imidazol
ring
residu
capabl
posit
charg
proton
result
surpris
light
fact
human
cytomegaloviru
serin
proteas
possess
catalyt
triad
wildtyp
noroviru
proteas
deproton
neg
charg
side
chain
interact
imidazol
ring
make
enzym
favour
catalysi
mutant
imidazol
ring
might
neutral
deproton
form
order
interact
imidazol
ring
mutant
activ
fig
wherea
mutant
even
bigger
side
chain
phenylalanin
residu
tyrosin
residu
unexpectedli
show
low
signific
proteas
activ
compar
wild
type
fig
may
pair
electron
n
atom
indol
ring
success
locat
abl
interact
context
pair
electron
atom
residu
mutant
may
contribut
hydrogen
bond
taken
togeth
result
indic
glutam
residu
requir
amino
acid
posit
residu
replac
hydrogen
bondform
amino
acid
asp
gln
asn
small
amino
acid
ala
cy
gli
ser
without
signific
loss
activ
latter
mutant
group
intrigu
possibl
water
molecul
may
act
manner
side
chain
glutam
although
investig
possibl
need
interest
met
trp
mutant
show
signific
activ
mutant
residu
posit
might
donat
pair
electron
interact
although
noroviru
proteas
chymotrypsinlik
fold
cystein
residu
instead
serin
residu
nucleophil
therefor
often
call
serinelik
cystein
proteas
fact
easili
lead
us
consid
possibl
noroviru
proteas
adopt
mechan
proteolysi
includ
ionpair
indic
studi
papain
typic
cystein
proteas
suggest
rhinoviru
proteas
one
chymotrypsinlik
cystein
proteas
ionpair
catalyt
compon
howev
third
member
catalyt
triad
polioviru
proteas
close
relat
rhinoviru
proteas
could
replac
glu
ala
thu
noroviru
proteas
toler
picornaviru
proteas
mutat
third
member
carboxyl
hand
report
contradict
possibl
viral
proteas
involv
ionpair
catalyt
mechan
kinet
studi
need
determin
mechan
proteolysi
adop
noroviru
proteas
gener
base
catalyt
mechan
ionpair
catalyt
mechan
case
note
noroviru
proteas
afford
accommod
variou
amino
acid
posit
exert
proteolysi
order
investig
mechan
proteolysi
thought
could
hint
know
effect
mutat
activesit
nucleophil
proteas
activ
attempt
sitesatur
mutagenesi
residu
background
mutat
mimick
catalyt
triad
typic
chymotrypsinlik
serin
proteas
shown
fig
singl
mutant
exhibit
slightli
lower
proteas
activ
wildtyp
thu
could
group
categori
ii
effect
mutat
mutant
contrast
wildtyp
proteas
mutat
support
proteolysi
background
kind
mutat
fig
judg
amount
intermedi
left
behind
fig
activ
mutant
slightli
less
mutant
turn
slightli
less
parent
singl
mutant
suggest
carboxyl
prefer
posit
background
residu
would
provid
pair
electron
abl
orient
imidazol
ring
contrast
mutant
show
proteolyt
activ
probabl
asparagin
side
chain
shorter
glutamin
side
chain
carbon
atom
result
failur
oper
interact
mutant
residu
although
aspart
side
chain
size
similar
asparagin
would
abl
provid
strong
neg
charg
interact
kind
amino
acid
requir
third
member
similar
chymotrypsin
asn
mutant
sever
defect
proteolysi
also
want
emphas
effect
mutat
quit
differ
wildtyp
proteas
particular
remark
ala
cy
gli
ser
mutat
mutat
neglig
wildtyp
proteas
inactiv
mutat
mutant
proteas
sh
oh
function
equival
proteolysi
effect
mutat
would
ident
case
experiment
result
suggest
sh
function
equival
oh
pka
valu
hydroxyl
group
serin
wherea
thiol
group
cystein
around
cy
sh
ioniz
ser
oh
easili
deproton
thiolat
thiolat
much
better
nucleophil
ser
oh
room
argument
regard
state
sh
group
noroviru
proteas
even
cy
sh
deproton
thiol
nucleophil
proton
readili
withdrawn
upon
nucleophil
attack
carbonyl
carbon
substrat
therefor
possibl
proteolysi
occur
without
larg
contribut
amino
acid
posit
wildtyp
background
background
abil
amino
acid
posit
interact
effect
requir
residu
posit
enhanc
nucleophil
hydroxyl
group
residu
character
proteas
mutant
proteas
well
wildtyp
purifi
gst
fusion
subject
assay
proteas
activ
use
fluorogen
peptid
describ
materi
method
section
sinc
junction
rapidli
cleav
polyprotein
produc
mammalian
cell
chose
peptid
includ
junction
vitro
assay
wildtyp
protein
cleav
peptid
effect
kcat
valu
cleavag
wildtyp
proteas
km
valu
mm
tabl
gst
protein
deriv
vector
proteolyt
activ
data
shown
therefor
increas
fluoresc
observ
assay
protein
attribut
proteas
moieti
fusion
hand
purifi
histag
proteas
show
proteolyt
activ
fusion
protein
data
shown
sinc
least
gst
moieti
seem
interfer
proteas
activ
fusion
protein
use
vitro
assay
effect
mutat
analys
singl
mutant
mutant
categori
mutant
categori
iv
chosen
expect
former
would
show
high
activ
compar
wildtyp
latter
would
high
activ
gst
fusion
mimick
precursor
form
judg
result
fig
among
five
singl
mutant
proteas
mutant
proteas
highest
proteas
activ
activ
wildtyp
proteas
tabl
suggest
capabl
form
hydrogen
bond
import
activ
howev
unabl
determin
kinet
constant
five
mutant
even
mutant
rate
proteolysi
alreadi
satur
lowest
substrat
concentr
test
activ
mutant
proteas
tend
lower
higher
concentr
substrat
data
shown
result
indic
glutam
appropri
residu
posit
clearli
sever
kind
amino
acid
residu
permiss
posit
order
exert
proteas
activ
hand
mutant
proteas
retain
moder
level
proteolyt
activ
kinet
constant
could
determin
success
tabl
although
kcat
valu
mutant
wildtyp
mutant
show
activ
wildtyp
kcatkm
valu
use
comparison
tabl
presenc
substrat
proteas
mutant
show
activ
wildtyp
tabl
indic
mutant
retain
rel
high
proteolyt
activ
addit
mutat
mutant
decreas
activ
tabl
parent
singl
mutant
degre
decreas
activ
almost
effect
mutat
wildtyp
proteas
suggest
side
chain
form
hydrogen
bond
favour
posit
regardless
nucleophil
notabl
mutat
affect
proteolyt
activ
wildtyp
proteas
mutant
proteas
complet
differ
manner
fig
residu
essenti
proteolysi
noroviru
proteas
clearli
requir
effect
proteolysi
indic
vitro
assay
proteolysi
although
mechan
proteolysi
remain
unclear
vitro
analys
would
requir
intrigu
possibl
noroviru
proteas
adopt
papainlik
mechan
involv
ion
pair
despit
fact
relat
structur
chymotrypsinlik
serin
proteas
also
noteworthi
cleavag
appear
preced
cleavag
proteolysi
judg
cleavag
event
mutant
fusion
protein
cleavag
site
occur
tran
intermolecularli
two
site
thought
equival
attack
proteas
moieti
howev
idea
deni
result
mutant
although
three
mutant
proteas
activ
least
precursor
form
intermedi
proteas
produc
indic
cleavag
event
occur
manner
differ
cleavag
event
suggest
ci
intramolecular
event
site
releas
mutant
proteas
inact
probabl
side
chain
posit
steric
hinder
proteolyt
reaction
result
led
us
assum
spatial
locat
posit
might
vari
depend
cleavag
event
elucid
crystal
structur
intermedi
fusion
protein
one
way
know
site
cleav
proteas
ministri
health
labour
welfar
japan
partli
support
grantinaid
none
declar
